<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36535372</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-3064</ISSN><JournalIssue CitedMedium="Internet"><Volume>207</Volume><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Respiratory medicine</Title><ISOAbbreviation>Respir Med</ISOAbbreviation></Journal><ArticleTitle>Long COVID outcomes in an asthmatic cohort and its implications for asthma control.</ArticleTitle><Pagination><StartPage>107092</StartPage><MedlinePgn>107092</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rmed.2022.107092</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0954-6111(22)00357-2</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Laorden</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Hospital La Paz, Universidad Aut&#xf3;noma de Madrid, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain. Electronic address: laordendaniel1@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dom&#xed;nguez-Ortega</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Allergy, Hospital La Paz, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carpio</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Hospital La Paz, Universidad Aut&#xf3;noma de Madrid, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barranco</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Allergy, Hospital La Paz, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villama&#xf1;&#xe1;n</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Hospital La Paz, IdiPAZ, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Hospital La Paz, Universidad Aut&#xf3;noma de Madrid, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quirce</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Allergy, Hospital La Paz, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;lvarez-Sala</LastName><ForeName>Rodolfo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Hospital La Paz, Universidad Aut&#xf3;noma de Madrid, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ASMA@COVIDHULP group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Respir Med</MedlineTA><NlmUniqueID>8908438</NlmUniqueID><ISSNLinking>0954-6111</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018927">Anti-Asthmatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018927" MajorTopicYN="Y">Anti-Asthmatic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Asthma</Keyword><Keyword MajorTopicYN="N">Chest pain</Keyword><Keyword MajorTopicYN="N">Cough</Keyword><Keyword MajorTopicYN="N">Dyspnea</Keyword><Keyword MajorTopicYN="N">Eosinophils</Keyword><Keyword MajorTopicYN="N">Inhaled corticosteroids</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Oral systemic corticosteroids</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors certify that none of them have any conflicts of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Camperos</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Hospital La Paz, Universidad Aut&#xf3;noma de Madrid, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain; Department of Allergy, Hospital La Paz, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Agrela</LastName><ForeName>Isamar</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Hospital La Paz, Universidad Aut&#xf3;noma de Madrid, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain; Department of Allergy, Hospital La Paz, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fern&#xe1;ndez-Concha</LastName><ForeName>In&#xe9;s</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Hospital La Paz, Universidad Aut&#xf3;noma de Madrid, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain; Department of Allergy, Hospital La Paz, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ernesto Freund</LastName><ForeName>Paul Kent</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Hospital La Paz, Universidad Aut&#xf3;noma de Madrid, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain; Department of Allergy, Hospital La Paz, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pav&#xf3;n</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Hospital La Paz, Universidad Aut&#xf3;noma de Madrid, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain; Department of Allergy, Hospital La Paz, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pose</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Hospital La Paz, Universidad Aut&#xf3;noma de Madrid, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain; Department of Allergy, Hospital La Paz, IdiPAZ, and CIBER of Respiratory Diseases, Madrid, Spain.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>19</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36535372</ArticleId><ArticleId IdType="pmc">PMC9755318</ArticleId><ArticleId IdType="doi">10.1016/j.rmed.2022.107092</ArticleId><ArticleId IdType="pii">S0954-6111(22)00357-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Borobia A.M., Carcas A.J., Arnalich F., &#xc1;lvarez-Sala R., Monserrat-Villatoro J., Quintana M., et al. A cohort of patients with COVID-19 in a major teaching hospital in Europe. J. Clin. Med. 2020;9:E1733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7356883</ArticleId><ArticleId IdType="pubmed">32512688</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W.-J., Hui C.K.M., Hull J.H., Birring S.S., McGarvey L., Mazzone S.B., et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir. Med. 2021;9:533&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8041436</ArticleId><ArticleId IdType="pubmed">33857435</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell D., Verma H., Ho K.S., Narasimhan B., Steiger D., Rogers L. Asthma and COVID-19: lessons learned and questions that remain. Expet Rev. Respir. Med. 2021;15:1377&#x2013;1386.</Citation><ArticleIdList><ArticleId IdType="pubmed">34570678</ArticleId></ArticleIdList></Reference><Reference><Citation>Habernau Mena A., Garc&#xed;a-Moguel I., Vazquez de la Torre Gaspar M., Mugica V., Alvarado Izquierdo M.I., Jimenez Blanco M.A., et al. COVID-19 course in allergic asthma patients: a Spanish cohort analysis. J. Asthma Allergy. 2022;15:257&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8881918</ArticleId><ArticleId IdType="pubmed">35228805</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J.H., Choi S.H., Yun K.W. Risk factors for severe COVID-19 in children: a systematic review and meta-analysis. J. Kor. Med. Sci. 2022;37(5):e35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8822112</ArticleId><ArticleId IdType="pubmed">35132841</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner J.O., Warner J.A., Munblit D. Hypotheses to explain the associations between asthma and the consequences of COVID-19 infection. Clin. Exp. Allergy. 2022;52:7&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34978737</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz X., Pilia F., Ojanguren I., Romero-Mesones C., Cruz M.J. Is asthma a risk factor for COVID-19? Are phenotypes important? ERJ Open Res. 2021;7(1) 00216-2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7667724</ArticleId><ArticleId IdType="pubmed">33527078</ArticleId></ArticleIdList></Reference><Reference><Citation>Novel coronaviris (nCoV) acute respiratory infection clinical characterisation data tools. nCoV case records form version 1.3. 24. https://media.tghn.org/medialibrary/2020/03/ISARIC_COVID19_CRF_V1.3_24Feb2020.pdf Feb 2020. Adapted from Sprint Sari Case Report form by ISARIC. Available online:</Citation></Reference><Reference><Citation>Reddel H.K., Bacharier L.B., Bateman E.D., Brightling C.E., Brusselle G.G., Buhl R., et al. Global initiative for asthma (GINA) strategy 2021 - executive summary and rationale for key changes. Am. J. Respir. Crit. Care Med. 2022;205(1):17&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8865583</ArticleId><ArticleId IdType="pubmed">34658302</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Torres-Macho J., Velasco-Arribas M., Arias-Naval&#xf3;n J.A., Guijarro C., Hern&#xe1;ndez-Barrera V., et al. Similar prevalence of long-term post-COVID symptoms in patients with asthma: a case-control study. J. Infect. 2021;83:237&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8089027</ArticleId><ArticleId IdType="pubmed">33957161</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmon P.A., Jackson D.J., Denlinger L.C. COVID-19 infections and asthma. J. Allergy Clin. Immunol. Pract. 2022;10:658&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613003</ArticleId><ArticleId IdType="pubmed">34838708</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>